Iodine in PDB 6kw9: Crystal Structure Analysis of Endo-Beta-1,4-Xylanase II Complexed with Xylotriose
Enzymatic activity of Crystal Structure Analysis of Endo-Beta-1,4-Xylanase II Complexed with Xylotriose
All present enzymatic activity of Crystal Structure Analysis of Endo-Beta-1,4-Xylanase II Complexed with Xylotriose:
3.2.1.8;
Protein crystallography data
The structure of Crystal Structure Analysis of Endo-Beta-1,4-Xylanase II Complexed with Xylotriose, PDB code: 6kw9
was solved by
C.Li,
Q.Wan,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
19.93 /
1.22
|
Space group
|
I 2 2 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
66.793,
67.799,
79.504,
90,
90,
90
|
R / Rfree (%)
|
14.5 /
15.9
|
Iodine Binding Sites:
The binding sites of Iodine atom in the Crystal Structure Analysis of Endo-Beta-1,4-Xylanase II Complexed with Xylotriose
(pdb code 6kw9). This binding sites where shown within
5.0 Angstroms radius around Iodine atom.
In total 4 binding sites of Iodine where determined in the
Crystal Structure Analysis of Endo-Beta-1,4-Xylanase II Complexed with Xylotriose, PDB code: 6kw9:
Jump to Iodine binding site number:
1;
2;
3;
4;
Iodine binding site 1 out
of 4 in 6kw9
Go back to
Iodine Binding Sites List in 6kw9
Iodine binding site 1 out
of 4 in the Crystal Structure Analysis of Endo-Beta-1,4-Xylanase II Complexed with Xylotriose
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 1 of Crystal Structure Analysis of Endo-Beta-1,4-Xylanase II Complexed with Xylotriose within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I203
b:96.3
occ:1.00
|
H
|
A:GLY112
|
2.7
|
9.1
|
1.0
|
HG22
|
A:THR109
|
3.2
|
13.4
|
1.0
|
N
|
A:GLY112
|
3.5
|
7.5
|
1.0
|
HA2
|
A:GLY112
|
3.6
|
9.7
|
1.0
|
H
|
A:ASP111
|
3.8
|
8.6
|
0.1
|
H
|
A:ASP111
|
3.8
|
8.6
|
0.9
|
CG2
|
A:THR109
|
3.9
|
11.2
|
1.0
|
HG21
|
A:THR109
|
3.9
|
13.4
|
1.0
|
CA
|
A:GLY112
|
4.0
|
8.1
|
1.0
|
N
|
A:ASP111
|
4.1
|
7.1
|
1.0
|
O
|
A:HOH423
|
4.1
|
14.1
|
1.0
|
HA
|
A:SER110
|
4.2
|
8.7
|
0.1
|
HG23
|
A:THR109
|
4.2
|
13.4
|
1.0
|
HA
|
A:SER110
|
4.3
|
8.7
|
0.9
|
C
|
A:SER110
|
4.4
|
7.0
|
0.9
|
C
|
A:SER110
|
4.5
|
7.0
|
0.1
|
C
|
A:ASP111
|
4.5
|
7.4
|
1.0
|
HA
|
A:ASP111
|
4.6
|
8.7
|
1.0
|
H
|
A:SER113
|
4.6
|
7.9
|
1.0
|
CA
|
A:ASP111
|
4.6
|
7.3
|
1.0
|
CA
|
A:SER110
|
4.7
|
7.2
|
0.1
|
CA
|
A:SER110
|
4.7
|
7.2
|
0.9
|
N
|
A:SER110
|
4.7
|
7.2
|
0.1
|
N
|
A:SER110
|
4.8
|
7.1
|
0.9
|
C
|
A:GLY112
|
4.8
|
7.6
|
1.0
|
HA3
|
A:GLY112
|
4.8
|
9.7
|
1.0
|
H
|
A:SER110
|
4.9
|
8.7
|
0.1
|
H
|
A:SER110
|
4.9
|
8.5
|
0.9
|
N
|
A:SER113
|
4.9
|
6.5
|
1.0
|
|
Iodine binding site 2 out
of 4 in 6kw9
Go back to
Iodine Binding Sites List in 6kw9
Iodine binding site 2 out
of 4 in the Crystal Structure Analysis of Endo-Beta-1,4-Xylanase II Complexed with Xylotriose
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 2 of Crystal Structure Analysis of Endo-Beta-1,4-Xylanase II Complexed with Xylotriose within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I204
b:13.9
occ:1.00
|
HH11
|
A:ARG142
|
2.8
|
12.2
|
1.0
|
HD2
|
A:ARG142
|
3.0
|
9.1
|
1.0
|
HD3
|
A:ARG142
|
3.1
|
9.1
|
1.0
|
HB
|
A:VAL114
|
3.3
|
8.0
|
1.0
|
CD
|
A:ARG142
|
3.5
|
7.6
|
1.0
|
NH1
|
A:ARG142
|
3.6
|
10.2
|
1.0
|
HB2
|
A:ARG142
|
3.9
|
8.0
|
1.0
|
HB3
|
A:ARG142
|
3.9
|
8.0
|
1.0
|
HG21
|
A:VAL114
|
4.0
|
8.9
|
1.0
|
HH12
|
A:ARG142
|
4.1
|
12.2
|
1.0
|
O
|
A:HOH552
|
4.1
|
15.6
|
1.0
|
HG23
|
A:VAL114
|
4.1
|
8.9
|
1.0
|
CB
|
A:VAL114
|
4.2
|
6.7
|
1.0
|
CB
|
A:ARG142
|
4.3
|
6.7
|
1.0
|
CG2
|
A:VAL114
|
4.3
|
7.4
|
1.0
|
H
|
A:VAL114
|
4.4
|
8.1
|
1.0
|
NE
|
A:ARG142
|
4.5
|
7.8
|
1.0
|
CG
|
A:ARG142
|
4.5
|
7.0
|
1.0
|
CZ
|
A:ARG142
|
4.5
|
8.6
|
1.0
|
HG11
|
A:VAL114
|
4.6
|
8.9
|
1.0
|
CG1
|
A:VAL114
|
4.9
|
7.4
|
1.0
|
|
Iodine binding site 3 out
of 4 in 6kw9
Go back to
Iodine Binding Sites List in 6kw9
Iodine binding site 3 out
of 4 in the Crystal Structure Analysis of Endo-Beta-1,4-Xylanase II Complexed with Xylotriose
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 3 of Crystal Structure Analysis of Endo-Beta-1,4-Xylanase II Complexed with Xylotriose within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I205
b:51.6
occ:1.00
|
HE21
|
A:GLN125
|
2.7
|
38.3
|
1.0
|
H
|
A:VAL123
|
2.8
|
22.1
|
1.0
|
HA
|
A:ARG122
|
3.2
|
15.8
|
1.0
|
NE2
|
A:GLN125
|
3.3
|
31.9
|
1.0
|
O
|
A:HOH343
|
3.6
|
29.5
|
1.0
|
HD2
|
A:ARG122
|
3.6
|
20.1
|
1.0
|
N
|
A:VAL123
|
3.6
|
18.4
|
1.0
|
HH11
|
A:ARG122
|
3.6
|
31.8
|
1.0
|
HE22
|
A:GLN125
|
3.7
|
38.3
|
1.0
|
HB
|
A:VAL123
|
3.7
|
26.6
|
1.0
|
HG3
|
A:GLN125
|
3.8
|
27.9
|
1.0
|
NH1
|
A:ARG122
|
4.0
|
26.5
|
1.0
|
HG2
|
A:GLN125
|
4.1
|
27.9
|
1.0
|
CA
|
A:ARG122
|
4.1
|
13.2
|
1.0
|
O
|
A:HOH321
|
4.1
|
35.7
|
1.0
|
O
|
A:GLN121
|
4.1
|
14.7
|
1.0
|
CD
|
A:GLN125
|
4.2
|
22.8
|
1.0
|
CG
|
A:GLN125
|
4.2
|
23.3
|
1.0
|
HH12
|
A:ARG122
|
4.2
|
31.8
|
1.0
|
O
|
A:VAL123
|
4.3
|
21.1
|
1.0
|
C
|
A:ARG122
|
4.4
|
15.9
|
1.0
|
HG23
|
A:VAL123
|
4.4
|
28.3
|
1.0
|
CB
|
A:VAL123
|
4.5
|
22.1
|
1.0
|
CA
|
A:VAL123
|
4.5
|
21.5
|
1.0
|
O
|
A:HOH345
|
4.5
|
32.0
|
1.0
|
CD
|
A:ARG122
|
4.5
|
16.8
|
1.0
|
HB3
|
A:ARG122
|
4.6
|
17.8
|
1.0
|
CZ
|
A:ARG122
|
4.7
|
26.9
|
1.0
|
CB
|
A:ARG122
|
4.9
|
14.8
|
1.0
|
C
|
A:VAL123
|
4.9
|
23.8
|
1.0
|
NE
|
A:ARG122
|
4.9
|
25.2
|
1.0
|
CG2
|
A:VAL123
|
5.0
|
23.6
|
1.0
|
|
Iodine binding site 4 out
of 4 in 6kw9
Go back to
Iodine Binding Sites List in 6kw9
Iodine binding site 4 out
of 4 in the Crystal Structure Analysis of Endo-Beta-1,4-Xylanase II Complexed with Xylotriose
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 4 of Crystal Structure Analysis of Endo-Beta-1,4-Xylanase II Complexed with Xylotriose within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I206
b:55.2
occ:1.00
|
OE1
|
A:GLN34
|
2.6
|
11.9
|
0.5
|
HE22
|
A:GLN34
|
2.7
|
13.9
|
0.5
|
HG
|
A:SER36
|
2.7
|
18.1
|
0.8
|
OG
|
A:SER36
|
3.1
|
6.1
|
0.2
|
HG
|
A:SER36
|
3.1
|
7.3
|
0.2
|
HA3
|
A:GLY30
|
3.1
|
11.4
|
1.0
|
CD
|
A:GLN34
|
3.3
|
9.9
|
0.5
|
NE2
|
A:GLN34
|
3.3
|
11.6
|
0.5
|
HG2
|
A:GLN34
|
3.3
|
12.1
|
0.6
|
OG
|
A:SER36
|
3.4
|
15.0
|
0.8
|
OG1
|
A:THR28
|
3.4
|
13.2
|
0.1
|
HG22
|
A:THR28
|
3.4
|
12.8
|
0.8
|
HB3
|
A:SER36
|
3.5
|
12.9
|
0.8
|
HB
|
A:THR28
|
3.6
|
11.4
|
0.8
|
HB2
|
A:SER36
|
3.7
|
12.9
|
0.2
|
HA
|
A:PHE35
|
3.8
|
8.6
|
1.0
|
CA
|
A:GLY30
|
3.8
|
9.5
|
1.0
|
HG21
|
A:THR28
|
3.8
|
12.8
|
0.8
|
H
|
A:SER36
|
3.8
|
8.6
|
1.0
|
HA2
|
A:GLY30
|
3.9
|
11.4
|
1.0
|
N
|
A:GLY30
|
3.9
|
7.8
|
1.0
|
CB
|
A:SER36
|
3.9
|
10.7
|
1.0
|
CG2
|
A:THR28
|
4.0
|
10.7
|
0.8
|
O
|
A:THR28
|
4.0
|
9.0
|
0.8
|
N
|
A:SER36
|
4.0
|
7.2
|
1.0
|
HG1
|
A:THR28
|
4.0
|
15.9
|
0.1
|
HB
|
A:THR28
|
4.0
|
11.4
|
0.1
|
H
|
A:GLY30
|
4.1
|
9.4
|
1.0
|
HE21
|
A:GLN34
|
4.1
|
13.9
|
0.5
|
CG
|
A:GLN34
|
4.2
|
10.1
|
0.6
|
C
|
A:PHE35
|
4.2
|
6.0
|
1.0
|
C
|
A:ASN29
|
4.3
|
7.7
|
1.0
|
CB
|
A:THR28
|
4.3
|
9.5
|
0.8
|
CB
|
A:THR28
|
4.3
|
9.5
|
0.1
|
O
|
A:THR28
|
4.4
|
7.7
|
0.1
|
CA
|
A:PHE35
|
4.4
|
7.2
|
1.0
|
CD
|
A:GLN34
|
4.5
|
16.9
|
0.6
|
O
|
A:ASN29
|
4.5
|
11.0
|
1.0
|
C
|
A:THR28
|
4.5
|
8.9
|
0.8
|
CA
|
A:SER36
|
4.6
|
7.1
|
1.0
|
HB3
|
A:GLN34
|
4.6
|
9.1
|
0.6
|
C
|
A:THR28
|
4.7
|
8.6
|
0.1
|
HD3
|
A:PRO31
|
4.7
|
14.2
|
1.0
|
CG
|
A:GLN34
|
4.7
|
8.3
|
0.5
|
HB3
|
A:GLN34
|
4.7
|
12.3
|
0.5
|
HB3
|
A:SER36
|
4.8
|
12.9
|
0.2
|
HB2
|
A:SER36
|
4.8
|
12.9
|
0.8
|
OE1
|
A:GLN34
|
4.8
|
22.6
|
0.6
|
HG3
|
A:GLN34
|
4.8
|
12.1
|
0.6
|
N
|
A:PHE35
|
4.8
|
6.4
|
1.0
|
HD2
|
A:PRO31
|
4.8
|
14.2
|
1.0
|
O
|
A:PHE35
|
4.8
|
7.2
|
1.0
|
HG23
|
A:THR28
|
4.9
|
12.8
|
0.8
|
O
|
A:GLN34
|
4.9
|
7.5
|
0.5
|
C
|
A:GLN34
|
4.9
|
6.5
|
0.5
|
C
|
A:GLN34
|
5.0
|
6.6
|
0.6
|
O
|
A:GLN34
|
5.0
|
7.0
|
0.6
|
HA
|
A:ASN29
|
5.0
|
9.6
|
1.0
|
|
Reference:
Z.Li,
X.Zhang,
C.Li,
A.Kovalevsky,
Q.Wan.
Studying the Role of A Single Mutation of A Family 11 Glycoside Hydrolase Using High-Resolution X-Ray Crystallography. Protein J. V. 39 671 2020.
ISSN: ISSN 1572-3887
PubMed: 33128114
DOI: 10.1007/S10930-020-09938-5
Page generated: Sun Aug 11 23:28:21 2024
|